Remove 2001 Remove Clinical Trials Remove Conditions Remove Medicine
article thumbnail

Best strains and terpenes for migraine relief

The Cannigma

Migraines are a peculiarly painful condition. Scientists still don’t understand exactly why migraines happen, nor how to cure the condition – but perhaps cannabis can help. A primary headache, such as a migraine, is its own condition, and not caused by a separate condition.

Terpenes 132
article thumbnail

Cannabis laws in Japan: Is weed legal?

The Cannigma

Japan does not have a medical cannabis program and does not allow the use of cannabis for patients seeking to treat a medical condition. In 2019, Japan approved clinical trials for Epidiolox — a cannabis derived medicine used to treat severe forms of childhood epilepsy such as Dravet and Lennox-Gastaut syndromes.

Law 137
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

SciSparc Announces Positive Topline Results For Proprietary Pain Management Compound In Pre-Clinical Study

Cannabis Law Report

(OTCQB: SPRCY ) a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments, today announced positive top-line results for its proprietary compound, SCI-160 in a controlled pre-clinical trial on neuropathic and post-operative pain.

article thumbnail

Pushing Cannabis into Modern Healthcare

CannaTech

Canada has been at the forefront of shaping much of the rhetoric surrounding cannabis since 2001. While Canada’s medicinal cannabis framework has gone through many iterations, Canada has led the way in showing to the world how to think about cannabis. The Need for Cannabis Education Tailored to Patient and Doctor.

article thumbnail

UK Baker & McKenzie Article – United Kingdom: London’s First Medical Cannabis Clinic Opens to Waiting List

Cannabis Law Report

As reported in the Guardian, Analytical Cannabis emphasises the importance of this for those suffering from conditions such as chronic pain, epilepsy and neurological and psychiatric disorders who have long been seeking access to what they hope is a transformative medicine. The product must be produced for medicinal use in humans.

article thumbnail

Paper: The transition of cannabis into the mainstream of Australian healthcare: framings in professional medical publications

Cannabis Law Report

Medicinal cannabis has been legalised for use for a range of specified medical conditions in Australia since 2016. Focusing on professional medical publications, this study sought to investigate how medicinal cannabis is being represented in professional medical publications. Published by The Journal of Cannabis Research.

article thumbnail

Psychedelic Invest’s 100 Most Influential People in Psychedelics List

Cannabis Law Report

Although psychedelics have been used by humans for over 7,000 years across multiple different cultures, only in the past century have these medicines been outlawed by governments around the world. Fortunately, the past several years have seen a resurgence in awareness and interest in psychedelic medicine. in/timferriss/ [link].